UDP Glucuronosyltransferase 2 Family, Polypeptide A3 (UGT2A3) Peptide
UGT2A3
Reactivité: Humain
Hôte: Synthetic
BP, WB
-
- Antigène Tous les produits UGT2A3
- UGT2A3 (UDP Glucuronosyltransferase 2 Family, Polypeptide A3 (UGT2A3))
- Origine
- Humain
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Attributs du produit
- This is a synthetic peptide designed for use in combination with anti-UGT2A3 antibody (Catalog #: ARP49862_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Indications d'application
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Conseil sur la manipulation
- Avoid repeated freeze-thaw cycles.
- Stock
- -20 °C
- Stockage commentaire
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Antigène
- UGT2A3 (UDP Glucuronosyltransferase 2 Family, Polypeptide A3 (UGT2A3))
- Synonymes
- UGT2A1 Peptide, zgc:112491 Peptide, 2010321J07Rik Peptide, RGD1308444 Peptide, Ugt2a3 Peptide, UDP glucuronosyltransferase 2 family, polypeptide A1, complex locus Peptide, UDP glucuronosyltransferase family 2 member A3 Peptide, UDP glucuronosyltransferase family 2 member A1 complex locus Peptide, UDP glucuronosyltransferase 2 family, polypeptide A3 Peptide, UDP-glucuronosyltransferase 2A3 Peptide, UDP-glucuronosyltransferase 2A3-like Peptide, UGT2A1 Peptide, UGT2A3 Peptide, LOC100351592 Peptide, LOC100359229 Peptide, ugt2a3 Peptide, LOC100596311 Peptide, Ugt2a3 Peptide, LOC100135631 Peptide
- Sujet
-
UGT2A3 belongs to the UDP-glycosyltransferase family. UDP-glucuronosyltransferases catalyze phase II biotransformation reactions in which lipophilic substrates are conjugated with glucuronic acid to increase water solubility and enhance excretion. They are of major importance in the conjugation and subsequent elimination of potentially toxic xenobiotics and endogenous compounds.
Alias Symbols: FLJ21934
Protein Size: 527 - Poids moléculaire
- 60 kDa
- ID gène
- 79799
- NCBI Accession
- NM_024743, NP_079019
- UniProt
- Q6UWM9
-
Vous êtes ici:
